OptimizeRx (OPRX) Asset Writedowns and Impairment (2022 - 2025)

OptimizeRx has disclosed Asset Writedowns and Impairment across 4 years of filings, most recently posting $368000.0 for Q4 2025.

• Asset Writedowns and Impairment for Q4 2025 came in at $368000.0, up 377.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $368000.0 (up 384.21% YoY), and the FY2025 annual result was $368000.0, up 76.92% from the prior year.
• Asset Writedowns and Impairment came in at $368000.0 for Q4 2025 at OptimizeRx, up from $77000.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $6.3 million in Q4 2023 to a low of -$1000.0 in Q3 2024.
• The 4-year median for Asset Writedowns and Impairment is $119500.0 (2023), against an average of $639792.7.
• Across the five-year window, Asset Writedowns and Impairment surged 2612.48% in 2023 and sank 100.42% in 2024, its largest moves.
• OptimizeRx's Asset Writedowns and Impairment stood at $230785.0 in 2022, then soared by 2612.48% to $6.3 million in 2023, then tumbled by 98.77% to $77000.0 in 2024, then jumped by 377.92% to $368000.0 in 2025.
• The last three Asset Writedowns and Impairment figures came in at $368000.0 (Q4 2025), $77000.0 (Q4 2024), and -$1000.0 (Q3 2024), per Business Quant data.